SEGYY yields 577.70% · PFE yields 6.13%● Live data
📍 SEGYY pulled ahead of the other in Year 1
Combined, SEGYY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEGYY + PFE for your $10,000?
SPT Energy Group Inc., an investment holding company, provides integrated oilfield services; and manufactures and sells oilfield services related products in the People's Republic of China, Kazakhstan, Turkmenistan, Canada, Singapore, Indonesia, the Middle East, and internationally. It operates through three segments: Drilling, Well Completion, and Reservoir. The company offers drilling services, including drilling rig, workover rig, complex well workover and fishing, cementing and drilling fluid services, etc., as well as rotary geosteering, vertical drilling, horizontal drilling, side tracking, underbalanced drilling, and fine managed pressure drilling technology services. It also provides well completion project design, well completion tools, and stimulation and fracturing services. In addition, the company offers geology research and oil reservoir research, dynamic monitoring, oil testing and recovery technology, coiled tubing service, and repair service of surface production devices, etc. Further, it is also involved in farming, trading, and manufacturing activities; the promotion of technology and application services; and the provision of gas operation and services. SPT Energy Group Inc. was founded in 1993 and is headquartered in Beijing, the People's Republic of China.
Full SEGYY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.